BMO Capital Downgrades TrueBlue (TBI) to Market Perform
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $9.94 +7.93%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Join SI Premium – FREE
BMO Capital downgraded TrueBlue (NYSE: TBI) from Outperform to Market Perform with a price target of $26.00 (from $35.00).
For an analyst ratings summary and ratings history on TrueBlue click here. For more ratings news on TrueBlue click here.
Shares of TrueBlue closed at $22.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Downgrades Compass Therapeutics (CMPX) to Neutral
- Cal-Maine Foods (CALM) PT Lowered to $80 at Stephens
- BMO Capital Starts Tenet Healthcare (THC) at Market Perform
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
